Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring
Diabetes/Endocrinology and Metabolism
Introduction: Intensive glycemic control minimizes the risks of microvascular complications in diabetes. A1C is a convenient estimate of mean blood glucose, but is not the only marker available. The practical use and limitations of alternative markers and continuous glucose monitors are the focus of this review.
Methods: PubMed and the Cochrane Library were searched for studies concerning applications or limitations of A1C, fructosamine, glycated albumin, 1,5-anhydroglucitol, skin autofluorescence, and continuous glucose monitoring. Papers reporting on strengths, limitations, or comparisons of these methods were reviewed for inclusion.
Results: A1C reflects three months of glycemic control and is not an ideal marker in all patient populations. Fructosamine and glycated albumin reflect mean blood glucose over three weeks. 1,5-Anhydroglucitol can measure hyperglycemic excursions in days to weeks. Continuous glucose monitors provide immediate feedback for timely intervention to reduce glycemic excursions and can assess glycemic variability. Current barriers to continuous glucose monitor use include inexperience, cost, discomfort, and medication interference.
Conclusions: Many promising alternative glycemic markers exist. The main limitations for all alternative methods of glycemic monitoring are a lack of standardization for clinically useful cut-offs or guidelines, and a lack of long-term data on their association with complications, particularly in varied patient populations.
Journal of Diabetes and its Complications
Lundholm, M. D.,
Emanuele, M. A.,
(2020). Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring. Journal of Diabetes and its Complications, 107585.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_mc/131